Cargando…
Prenatal Diagnosis and Treatment of Steroid 21-Hydroxylase Deficiency
Steroid 21-hydroxylase deficiency (21-OHD) accounts for 90–95% of congenital adrenal hyperplasia (CAH) cases. It is classified into three distinct clinical phenotypes: the salt-wasting (SW), simple virilizing (SV) and nonclassical forms (NC). As girls with the SW and SV forms of 21-OHD are exposed t...
Autores principales: | Tajima, Toshihiro, Fujieda, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004826/ https://www.ncbi.nlm.nih.gov/pubmed/24790370 http://dx.doi.org/10.1297/cpe.17.95 |
Ejemplares similares
-
Neonatal mass screening for 21-hydroxylase deficiency
por: Tajima, Toshihiro, et al.
Publicado: (2016) -
Health problems of adolescent and adult patients with 21-hydroxylase
deficiency
por: Tajima, Toshihiro
Publicado: (2018) -
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014
revision)
por: Ishii, Tomohiro, et al.
Publicado: (2015) -
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase
deficiency (2021 revision)
por: Ishii, Tomohiro, et al.
Publicado: (2022) -
Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach
por: Arriba, María, et al.
Publicado: (2022)